Agenda

Welcome and Introduction
Prachi Bogetto, GE Healthcare, Piscataway, NJ

"Advances in Biacore Methodologies: Single cycle kinetics, calibration free concentration analysis and new approaches for immunogenicity assays"
Robert Karlsson, Biacore R&D, GE Healthcare, Uppsala, Sweden

"Using Biacore to dissect protein-protein interactions and develop protein therapeutics"
Eric J. Sundberg, Boston BioMedical Research Institute, Watertown, MA

"Characterization of human Mabs against cancer and infectious disease using Biacore T100"
Jianhua Sui, Dana-Farber Cancer Institute, Boston, MA

"Fragments to biologics; Targeting the IL-13 pathway for asthma"
Lori Fitz, Wyeth Research, Cambridge, MA

"The use of Biacore technology in the infectious diseases drug discovery process"
Gregg Chenail, Novartis Institutes for BioMedical Research, Cambridge, MA

"Allosteric Small Molecule Inhibitors of MEK"
Adam Shutes, EMD Serono Research Institute, Rockland, MA